Among the 23 analysts who follow Palantir, the median target price of $39 per share implies 62% downside from the current ...

Value-focused billionaire asset managers are trading out pricey stocks for perceived-to-be safe, income-producing, brand-name businesses.

Martin Shkreli, the former hedge fund manager known as "Pharma Bro," defended Palantir Technologies Inc.'s valuation on Tuesday amid the company's surging stock price, projecting substantial cash flow ...

Ahead of the long break for the Lunar New Year, the China stock market had ended the two-day winning streak in which it had improved ...

Calm returned to Wall Street, and tech stocks led U.S. indexes higher after a strong profit report from Palantir Technologies ...

The table below lists the S&P 500's top sectors by weighting as of Jan. 27, 2025. The information technology, financials, health care, and consumer discretionary sectors carry a cumulative weight of ...

Learn more about whether Blueprint Medicines Corporation or Zai Lab Limited is a better investment based on AAII's A+ ...

The domestic equity benchmarks soared on Tuesday, buoyed by the U.S. decision to postpone its planned tariffs on Canada and Mexico. The move offered a temporary reprieve from escalating trade tensions ...

For ICICI Securities, Poly Medicure’s Q3 performance was lower than expected. The company reported a 21 per cent YoY growth ...

Learn more about whether Atkore Inc. or EnerSys is a better investment based on AAII's A+ Investor grades, which compare both ...

Indian share market is slated to open lower on Monday, tracking weak cues from global peers and bearish trend at Gift Nifty.

Stocks including Coal India, Lupin, Power Grid, Indian Bank, Happiest Minds, GR Infraprojects, Anant Raj, MOIL and more will ...